Summary
The FDG method, as it is applied in clinical PET studies is reviewed. The influence of different implementations of the method and instrumental inaccuracies on the values of cerebral metabolic rate of glucose is discussed. For the comparison of the results between different groups standardized procedures are recommended.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baron JC, Rougemont D, Soussaline F, Bustany P, Crouzel C, Bousser MG, Comar D (1984) Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab 4: 140–149
Bergström M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widén L (1981) Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 5: 136–141
Bergström M, Litton J, Eriksson L, Bohm C, Blomqvist G (1982) Determination of object contour from projections for attenuation correction in cranial positron emission tomography. J Comput Assist Tomogr 6: 365–372
Brooks RA (1982) Alternative formula for glucose utilization using labelled deoxyglucose. J Nucl Med 23: 528–539
Gjedde A, Wienhard K, Heiss WD, Kloster G, Diemer NH, Herholz K, Pawlik G (1985) Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant. J Cereb Blood Flow Metab 5: 163–178
Hawkins RA, Phelps ME, Huang SC, Kuhl DE (1981) Effect of ischemia on quantification of local cerebral glucose metabolic rate in man. J Cereb Blood Flow Metab 1: 37–51
Hawkins RA, Phelps ME, Huang SC (1986) Effects of temporal sampling, glucose metabolic rates and disruptions of the blood brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumours with PET. J Cereb Blood Flow Metab 6: 170–183
Heiss WD, Wienhard K, Pawlik G, Wagner R, Ilsen HW, Herholz K (1983) Hypo-metabolism in stroke: cerebral metabolic rate for glucose in infarcted and remote tissue obtained by dynamic determination of individual kinetic constants. In: Greitz T, Ingvar DH, Widén L (eds) The metabolism of the human brain studied with positron emission tomography. Raven Press, New York, pp 399–409
Herholz K (1988) Non-stationary spatial filtering and accelerated curve fitting for parametric imaging with dynamic PET. Eur J Nucl Med 14: 477–484
Herholz K, Patlak CS (1987) The influence of tissue heterogeneity on results of fitting non-linear model equations to regional tracer uptake curves: with an application to compartmental models used in positron emission tomography. J Cereb Blood Flow Metab 7: 214–229
Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238: 569–582
Huang SC, Carson RE, Phelps ME, Hoffman EJ, Schelbert HR, Kuhl DE (1981) A boundary method for attenuation correction in positron computed tomography. J Nucl Med 22: 627–637
Hutchins GD, Holden JE, Koeppe RA, Halama JR, Gatley SJ, Nickles RI (1984) Alternative approaches to single scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia. J Cereb Blood Flow Metab 4: 35–40
Lammertsma AA, Brooks DJ, Frackowiak RSJ, Beaney RP, Herold S, Heather JD, Palmer AJ, Jones T (1987) Measurement of glucose utilization with (18F)2-fluoro-2deoxy-D-glucose: a comparison of different analytical methods. J Cereb Blood Flow Metab 7: 161–172
Mazoyer BM, Huesman RH, Budinger TF, Knittel BL (1986) Dynamic PET data analysis. J Comput Assist Tomogr 10: 645–653
Michel C, Bol A, De Volder AG, Goffinet AM (1989) Online brain attenuation correction in PET: towards a fully automated data handling in a clinical environment. Eur J Nucl Med 15: 712–718
Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3: 1–7
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2fluoro-2-deoxy-D-glucose: validation of the model. Ann Neurol 6: 371–388
Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Sokoloff L (1979) The 18F-fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44: 127–137
Reivich M, Alavi A, Wolf A, Fowler J, Arnett C, MacGregor RR, Shiue CY, Atkins H, Anand A, Dann R, Greenberg JH (1985) Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for 18F-fluorodeoxyglucose and 11C-deoxyglucose. J Cereb Blood Flow Metab 5: 179–192
Rhodes CG, Wise RJS, Gibbs JM, Frackowiak RSJ, Hatazawa J, Palmer AJ, Thomas DGT, Jones T (1983) In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol 14: 614–626
Sasaki H, Kanno I, Murakami M, Shishido F, Uemura K (1986) Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography. J Cereb Blood Flow Metab 6: 447–454
Sokoloff L, Reivich M, Kennedy C, DesRosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The 14C-deoxyglucose method for the measurement of local cerebral glucose utilisation: theory, procedure and normal values in the conscious and anaesthetized albino rat. J Neurochem 28: 897–916
Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss WD (1985) Estimation of local cerebral glucose utilisation by positron emission tomography of 18F-2-fluoro-2deoxy-D-glucose: a critical appraisal of optimisation procedures. J Cereb Blood Flow Metab 5: 115–125
Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD (1991) Estimation of local cerebral glucose utilisation by positron emission tomography: comparison of (18F)-2-fluoro-2-deoxy-D-glucose and (18F)-2-fluoro-2deoxy-D-mannose in patients with focal brain lesions. J Cereb Blood Flow Metab 11: 485–491
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag
About this paper
Cite this paper
Wienhard, K. (1992). The FDG model and its application in clinical PET studies. In: Ågren, H., Martinot, JL., Wiesel, FA. (eds) Studies of Brain Metabolism in Psychiatric Patients: Can Standards Be Drawn?. Journal of Neural Transmission, vol 37. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9209-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9209-2_4
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82346-0
Online ISBN: 978-3-7091-9209-2
eBook Packages: Springer Book Archive